[go: up one dir, main page]

DE69625189D1 - Tablette mit gesteuerter freisetzung - Google Patents

Tablette mit gesteuerter freisetzung

Info

Publication number
DE69625189D1
DE69625189D1 DE69625189T DE69625189T DE69625189D1 DE 69625189 D1 DE69625189 D1 DE 69625189D1 DE 69625189 T DE69625189 T DE 69625189T DE 69625189 T DE69625189 T DE 69625189T DE 69625189 D1 DE69625189 D1 DE 69625189D1
Authority
DE
Germany
Prior art keywords
controlled release
release tablet
tablet
controlled
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69625189T
Other languages
English (en)
Inventor
Cherng-Ju Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple Univ School of Medicine
Original Assignee
Temple Univ School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple Univ School of Medicine filed Critical Temple Univ School of Medicine
Application granted granted Critical
Publication of DE69625189D1 publication Critical patent/DE69625189D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
DE69625189T 1995-02-28 1996-02-28 Tablette mit gesteuerter freisetzung Expired - Lifetime DE69625189D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39579295A 1995-02-28 1995-02-28
PCT/US1996/002290 WO1996026718A2 (en) 1995-02-28 1996-02-28 Controlled release tablet

Publications (1)

Publication Number Publication Date
DE69625189D1 true DE69625189D1 (de) 2003-01-16

Family

ID=23564527

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625189T Expired - Lifetime DE69625189D1 (de) 1995-02-28 1996-02-28 Tablette mit gesteuerter freisetzung

Country Status (11)

Country Link
EP (1) EP0821582B1 (de)
JP (1) JPH11509169A (de)
AR (1) AR003928A1 (de)
AT (1) ATE228829T1 (de)
AU (1) AU722741B2 (de)
CA (1) CA2213455A1 (de)
DE (1) DE69625189D1 (de)
MY (1) MY113429A (de)
PA (1) PA8388101A1 (de)
TW (1) TW431891B (de)
WO (1) WO1996026718A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
AU7888298A (en) * 1997-01-03 1998-07-31 Elan Corporation, Plc Sustained release cisapride minitablet formulation
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
JP2003521507A (ja) 2000-02-04 2003-07-15 ディポメド，インコーポレイティド ゼロ次薬物放出に接近するシェル−コア剤形
US6723340B2 (en) 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
KR20050111318A (ko) 2003-01-13 2005-11-24 다이노젠 파마세우티컬스, 인코포레이티드 기능성 장 질환을 치료하는 방법
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
EA011446B1 (ru) 2004-06-17 2009-02-27 Форест Лэборэтериз, Инк. Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
KR20080080094A (ko) 2005-10-14 2008-09-02 하. 룬트벡 아크티에 셀스카브 에스시탈로프람 및 부프로피온의 저용량 조합물을 이용한중추신경계 장애의 치료 방법
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US20070202164A1 (en) * 2006-02-28 2007-08-30 Hutchison Medipharma Enterprises Limited Andrographis Extract Formulations
WO2010026467A2 (en) 2008-09-04 2010-03-11 Torrent Pharmaceuticals Ltd. Controlled release dosage form of high solubility active ingredient
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US8828953B2 (en) 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
CN102481276A (zh) 2009-04-20 2012-05-30 埃尔舍利克斯治疗公司 基于化学感受受体配体的治疗法
MX2013004364A (es) 2010-10-19 2013-07-02 Elcelyx Therapeutics Inc Terapias a base de ligando del receptor quimiosensorial.
CN103597071A (zh) 2011-01-07 2014-02-19 埃尔舍利克斯治疗公司 基于化学感应受体配体的治疗
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
EP3003297A4 (de) 2013-06-05 2017-04-19 Synchroneuron Inc. Acamprosat-formulierungen, verfahren zur verwendung davon und kombinationen damit
US9617230B2 (en) 2014-12-22 2017-04-11 Farmington Pharma Development Creatine prodrugs, compositions and methods of use thereof
WO2019109067A2 (en) 2017-12-01 2019-06-06 Ultragenyx Pharmaceutical Inc. Creatine prodrugs, compositions and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252338A (en) * 1991-06-27 1993-10-12 Alza Corporation Therapy delayed

Also Published As

Publication number Publication date
AR003928A1 (es) 1998-09-30
WO1996026718A3 (en) 1996-10-10
TW431891B (en) 2001-05-01
CA2213455A1 (en) 1996-09-06
AU722741B2 (en) 2000-08-10
AU5171196A (en) 1996-09-18
EP0821582B1 (de) 2002-12-04
JPH11509169A (ja) 1999-08-17
WO1996026718A2 (en) 1996-09-06
MY113429A (en) 2002-02-28
EP0821582A2 (de) 1998-02-04
PA8388101A1 (es) 1997-09-30
ATE228829T1 (de) 2002-12-15

Similar Documents

Publication Publication Date Title
DE69625189D1 (de) Tablette mit gesteuerter freisetzung
ATE200864T1 (de) Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
DE69617245D1 (de) Produkte mit gesteuerter freisetzung
DE69128569D1 (de) Tablette mit verzögerter Wirkstoffabgabe
DK0840634T3 (da) Transcornealt lægemiddelfrigivelsessystem
GB9501127D0 (en) Tablet
DE69620003D1 (de) Freisetzungssysteme
NO962510D0 (no) Dobbel-væskemedikamentfordeler
DE69401971D1 (de) Magnetothermische Auslöseeinheit
DE69625954D1 (de) Standbildkamera
IL123614A0 (en) Chewable tablet
AU128017S (en) Pharmaceutical tablet
BR9600809A (pt) Medicamento
FR2737885B3 (fr) Distributeur de comprimes
AU129056S (en) Pharmaceutical tablet
ATE269695T1 (de) Pharmazeutische pellets
BR9610193A (pt) 4-Tiocarbamoil-1-(2-Pirazolil)-pirazóis
ATE240096T1 (de) Schnellfreisetzende komprimierte flurbiprofen enthaltende tablette
KR970008018U (ko) 장제용 위패
DE19680143T1 (de) Fotoapparat
SE9500250D0 (sv) Portionstabletter
UA1292S (uk) Таблетка фармацевтична
FI950008L (fi) Farmaseuttinen koostumus kontrolloitua vapautumista varten
CA77348S (en) Tablet
DE69617790D1 (de) Synchronisierter Zeitschalter

Legal Events

Date Code Title Description
8332 No legal effect for de